2. Academic Validation
  3. Double-component diazeniumdiolate derivatives as anti-cancer agents

Double-component diazeniumdiolate derivatives as anti-cancer agents

  • Bioorg Med Chem. 2020 Apr 15;28(8):115405. doi: 10.1016/j.bmc.2020.115405.
Xun Ji 1,  Qi Chen 2,  Viswanath Arutla 1,  Omar Khdour 1,  Qiong-Ying Hu 3,  Shengxi Chen 4
Affiliations

Affiliations

  • 1 Biodesign Center for BioEnergetics, Arizona State University, Tempe, AZ 85287, USA.
  • 2 Department of Central Laboratory, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, PR China.
  • 3 Department of Central Laboratory, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, PR China; School of Medcine, Taizhou University, Taizhou, Zhejiang, PR China. Electronic address: qiongyinghu@tzc.edu.cn.
  • 4 Biodesign Center for BioEnergetics, Arizona State University, Tempe, AZ 85287, USA. Electronic address: shengxi.chen.1@asu.edu.
PMID: 32156499 DOI: 10.1016/j.bmc.2020.115405
Abstract

In this study, we synthesized a series of double-component O2-aryl diazeniumdiolate (DDNO) derivatives, of which each molecule can release up to four nitric oxide molecules. These compounds showed cytotoxic activities to Cancer cells, such as human leukemia, breast Cancer and lung Cancer. Among them, compound 1 (DDNO-1) showed the highest specific activity to human leukemia cells. It induced cell apopotosis and arrest cell cycle of G2/M phase. The JNK and p38 protein kinases were activated by compound 1 to induce Cancer cell Apoptosis. Compound 1 also increased pro-apoptotic Bax level, which is a same function compared to a reported NO donor, JS-K. More interestingly, it decreased the level of an anti-apoptotic member Bcl-2, which is an opposite effect compared to JS-K. Compound 1 could be developed as a new anti-cancer agent since it increases the Bax/Bcl-2 ratio to overcome the drug resistance.

Keywords

Anti-cancer agent; Bcl-2 inhibitor; Diazeniumdiolate derivatives; G2/M phase arrest; Leukemia; Nitric oxide.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z